目的:通过四氢吡咯二硫代氨基甲酯(PDTC)研究核因子-κB(NF-κB)对人脐静脉内皮细胞模拟缺血再灌注后趋化因子CXCL16表达的影响。方法:分为5组对人脐静脉内皮细胞进行培养,即对照组(正常培养基培养)、缺血再灌注组(模拟缺血培养液培养30min后换正常培养液再培养4h)、缺血再灌注+0.1mmol/L PDTC组、缺血再灌注+0.25mmol/L PDTC组和缺血再灌注+0.5mmol/L PDTC组。后3组均于模拟缺血再灌注培养前1h在培养液中添加相应浓度PDTC。观察各组NF-κB p65及CXCL16mRNA表达水平,通过ELISA检测CXCL16蛋白表达水平以及细胞存活情况。结果:缺血再灌注组显著刺激CXCL16的mRNA和蛋白表达水平(均P〈0.05)。0.1mmol/L、0.25mmol/L和0.5mmol/L PDTC均显著降低NF-κB mRNA和CXCL16mRNA(均P〈0.05)。0.5mmol/L PDTC显著降低上清培养液CXCL16蛋白表达水平(P〈0.05)。0.1mmol/L、0.25mmol/L和0.5mmol/L PDTC均促进细胞存活(均P〈0.05)。结论:PDTC抑制模拟缺血再灌注所诱导的CXCL16表达,有利于细胞生存。
Objective: To investigate the regulation mechanism of CXCL16 after mimic ischemia/reperfusion culture of human umbilical vein endothelial cells (HUVECs) with the utilization of PDTC. Method: HUVECs were divided into 5 groups: control group (culture with normal media), mimic ischemia/reperfusion group (mimic is- chemic media cultured for 30 min followed by normal media cultured for 4 h), mimic ischemia/reperfusion group is+0. 1 m mol/L PDTC group, mimic ischemia/reperfusion group +0.25 m mol/L PDTC group and mimic ische- mia/reperfusion group +0.5 m mol/L PDTC group. For the latter 3 groups, HUVECs were treated with PDTC 1 h before mimic ischemia/reperfusion. The inhibition efficiency of PDTC on the mRNA and protein levels of p65, the expression of CXCLI6 mRNA and protein as well as cell survival were determined by real-time PCR, ELISA and WST assay respectively. Result:The mRNA and protein levels of CXCL16 were significantly increased by mim- ic ischemia/reperfusion (both P〈0.05). 0.1,0.25 and 0.5 mmol/L PDTC significantly decreased mRNA levels of NF-κB and CXCL16 (both P〈0.05). 0.5 mmol/L PDTC significantly suppressed supernatant CXCL16 protein level (P〈0.05). 0.1, 0.25 and 0.5 mmol/L PDTC promoted cell survival (all P〈0.05). Conclusion:PDTC inhibited mimic ischemic/reperfusion-induced expression of CXCL16 and promoted the survival of HUVECs.